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INTRODUCTION
Progression of the cell cycle is promoted by cyclin dependent kinases (CDKs). The activity of cyclin-CDK complexes is regulated by various mechanisms, including association of the kinase subunit with the regulatory cyclin subunit, phosphorylation-dephosphorylation of the kinase subunit, and association of the complex with CDK inhibitors (CKIs). 1, 2 To date, seven CKIs have been identified in mammals, and these proteins are classified into two families on the basis of their amino acid sequence similarity and putative targets. 3, 4 The Cip or Kip family comprises p21 Cip1 , p27 Kip1 and p57 Kip2 , each of which possesses a conserved domain, termed the CDK binding-inhibitory domain, at its NH 2 terminus. The Ink4 family consists of p16 Ink4A , p15 Ink4B , p18 Ink4C and p19 Ink4D , and its members each contains four tandem repeats of an ankyrin motif. Whereas members of the Ink4 family inhibit the activity of CDK4 or CDK6 specifically, members of the Cip-Kip family inhibit a broad spectrum of cyclin-CDK complexes.
p57 Kip2 is ubiquitousoly expressed in the whole embryo and its signal decreases during development. 5, 6 The human p57 Kip2 gene is located on chromosome 11p15.5, a site of frequent loss of heterozygosity in several human cancers. 7, 8 Furthermore, rearrangements at 11p15 are apparent in individuals with Beckwith-Wiedemann syndrome, which is characterized by numerous developmental abnormalities as well as a 1,000-fold increase in the risk of childhood tumors. [9] [10] [11] Mice lacking p57 Kip2 die immediately after birth as a result of dyspnea caused by severe cleft palate. They also show abdominal muscle defects and skeletal abnormalities due to defects in endochondral ossification. [12] [13] [14] The p57 Kip2 gene was recently isolated as a target of the p73β transcription factor, one member of the p53 family. 15 It is interesting to note however that p73 null mice show several developmental defects including hydrocephalus, hippocampal dysgenesis, inflammatory and neuronal defects, 16 but none of these defects resembles the phenotype of p57 Kip2 null mice as it should be the case if the two genes are linked to the same regulatory pathway or belong to a common signaling cascade. Instead, the phenotype of the p57 Kip2 null mice is similar to the knockout phenotypes of p63, the other member of the p53 family: 17, 18 p63 null mice have severe cranio facial defects, skin and limbs deficiencies and patients affected by syndromes associated to p63 mutations have cleft palate, limbs deformities and ectodermal dysplasia. 19, 20 To date, several mutations in the p63 gene have been identified associated to several distinct human developmental syndromes, characterized by common features such as limb abnormalities, ectodermal dysplasia, and facial clefts. 19 These syndromes are: the Ectrodactyly-Ectodermal dysplasia facial Clefts (EEC), the Ankyloblepharon-Ectodermal dysplasia-Clefting (AEC), the Limb-Mammary Syndrome (LMS), the Acro-Dermato-UngualLacrimal-Tooth (ADULT), and non syndromic Split-Hand/ split-Foot Malformation-4 (SHFM-4). The distribution of mutations over the various p63 protein domains, and the structural and functional implications of these mutations establish a clear genotypephenotype correlation. 20 The similarities between the p57 Kip2 and p63 null mice suggested us the possibility that the two genes might be linked to the same regulatory pathway or belong to a common signaling cascade with p63 possibly regulating p57 Kip2 expression. Here we report that the ∆Np63α isoform is bound to the p57 kip2 promoter in vivo and that a 2 Kb p57 Kip2 promoter fragment is activated by the ∆Np63s and repressed by the TAp63s isoforms in different cell lines. Moreover, natural p63 mutations, in particular the AEC mutation (Fig. 1) , were indeed altered in their capacity to regulate p57 Kip2 transcription reinforcing the hypothesys that these two genes might be linked to a common regulatory pathway.
MATERIALS AND METHODS
Cell culture and transfection. The human osteosarcoma Saos-2 cell line was manteined in RPMI 1640 medium and 10% fetal calf serum. The murine mesenchymal stem cell line C3H10T(1/2), and the human osteosarcoma U2OS cell line were manteined in Dulbecco's modified Eagle's medium (D-MEM) and 10% fetal calf serum. For transfection, 80000 cells were seeded into 24-well multiplates and on the next day transfected with Lipofectamine 2000 (Invitrogen) under the condition suggested by the manifacturer. The total amount of transfected DNA (1 µg) was kept costant using empty vector when necessary. Thirthy six hours later, cells were lysed and assayed for luciferase activity. The human keratinocyte HaCat cell line was manteined in D-MEM medium supplemented with 10% fetal calf serum. HaCat cells were transfected with Fugene (Roche) under the condition suggested by the manifacturer.
Plasmids. The p63 plasmids were kindly provided by Dr. H. Van Bokhoven. 19 The -2191Kip2, -1550Kip2 and -595Kip2 promoter constructs were kindly provided by Dr. O. Dellatre. 21 The -1091Kip2 promoter construct was kindly provided by Dr. K. Vousden. 15 The -2091Kip2, -1891Kip2, -1791Kip2 and -1664Kip2 constructs were generated by PCR: different oligonucleotide pairs were synthetized in order to obtain progressive deletion of the p57Kip2 promoter. The sequences of the oligonucleotides were as follows: -2091Kip2 forward: TTCGGAGCTCGGTAAAGTGGAAAAATAAAAGTA, -1891Kip2 forward: TTCGGAGCTCTGGAGTGTGGGTATCCGGG, -1791Kip2 forward: TTCGGAGCTCACTTTGCCTCTTTCTGCCC, -1664Kip2 forward: TTCGGAGCTCGCGGGAAATTTGTAAATTGTGC. The revers primer for all reactions was HpaI: GAGACAGGGCGTTAACCCA.
All oligonucleotides contain adequate restriction sites (underlined) to allow further cloning steps: the amplification products were purified and cloned in the pCR 2,1-TOPO vector under the conditions suggested by the manifacturer (Promega). The cloned fragments were digested with SacI and HpaI, purified and ligated in the -2191Kip2 vector, partially digested with SacI and HpaI.
Immunoblot analysis. Thirthy-six hours after transfection cells were lysed in 60 µl of loading buffer (2% sodium dodecyl sulfate, 30% glycerol, 300 µM β-mercaptoethanol, 100 mM Tris-HCl ph 6.8): 15 µλ of total extracts were separeted on a SDS-10% polyacrylammide gels and transferred to a nitrocellulose membrane (Scleicher and Schuell). The blots were incubated with the p57 Kip2 C-20 antibody (Santa Cruz Biotecnology) and developed according to the manufacturee's instructions (Super Signal, Pierce).
Chromatin immunoprecipitations. Exponentially growing HaCat cells were washed in PBS, incubated for ten minutes with 1% formaldehyde and quenched with Glycine 0.1 M. Cells were sonicated and chromatin fragments of an average length of 1 Kb recovered by centrifugation. Immunoprecipitations were performed with ProtG-Sepharose (KPL, USA), blocked twice at 4˚C with 1 µg/ml salmon sperm DNA sheared at 500 bp length and 1 µg/ml BSA, for two hours and overnight. Chromatin was precleared by adding ProtG-Sepharose for two hours at 4˚C, aliquoted and incubated with 3-5 µg of the NF-YB purified rabbit polyclonal and p63 antibodies overnight at 4˚C. DNA was released by incubating samples for five hours at 65˚C, phenol-extracted and ethanol precipitated. Semi quantitative PCRs were performed with the following primers: -2500 forward: AGGGTATGTAACGCCCCACTGT -2500 reverse: TGTCAGGAACGCTGTACACCAC -1600 forward: TGATGGCAGCTACACCCTCTGA -1600 reverse: CTTGGCTCTTGATGGTGGAACC core prom for: CCCGCCTGCAGACAAAGGAG core prom rev: CGGCCGCGATTAGCATAATGTAG +1000 forward: CTCCTCCCGTGGCATTAAAGG +1000 reverse: CGCAATGTGCTGTGTAAGCATT +5000 forward: TGGTGCATACAAAGGTGGTTGG +5000 reverse: CTAGGGAGGAGGGAGGGATGAA To produce the anti-p63 antibodies, we cloned TAp63α (Aminoacids 47-611) and SAM-p63, containing the SAM domain (Aminoacids 508-611) into the PET32β prokaryotic expression vector (Novagen, USA). Recombinant TA-p63 was used to immunize two rabbits. The sera were affinity-purified over two different columns derivatized with the TAp63 and SAM-p63 proteins, respectively. We obtained purified antibodies against (1) the whole protein and (2) specific against to the alpha isoforms. The antibodies were checked in Western blots on all p63 isoforms overexpressed in eukaryotic cells. The SAM-p63 abs were indeed >10 enriched for anti-TA and ∆Np63α antibodies (not shown).
Regulation of the Cyclin-Dependent Kinase Inhibitor p57 Kip2 Expression by p63 Figure 1 Schematic representation of p63 structure. Intron-exon structure of the p53 and p63 genes, showing the p63 transcriptional start sites and the alternative splicing at the 3' end that gives rise to the α, β and γ isoforms. The changes in the reading frame within exons 14 and 15 occuring in the β and γ isoforms are indicated. The positions of the four natural p63 mutations associated to the EEC, AEC, LMS and SHFM-4 syndromes are indicated. All these mutations affect only the α isoforms.
Regulation of the Cyclin-Dependent Kinase Inhibitor p57 Kip2 Expression by p63 RNA analysis. For RNA analysis, 800,000 Saos-2 and U2OS cells were seeded in 100 mm plates. The next day 5 µg of p63 plasmids were transfected with Lipofectamine 2000 (Invitrogen) according to the manifacturer conditions. Total RNA was prepared with TRIzol reagent (Sigma). For reverse transcription (RT)-PCR detection of gene expression, 3 µg of total RNA was reverse-transcribed using Super Script II (Invitrogen). Total RNA was extracted from growing HaCaT cells with the RNAeasy kit (Qiagen). Three micrograms were reverse transcribed using the Super Script II (Invitrogen).
The following oligonucleotides were used for gene amplification:
The oligonucleotidess for the p57 Kip2 PCR were described, 22 forward: TCGCTGCCCGCGTTTGCGCA reverse: CCGAGTCGGTGTCCACTTCGG GAPDH forward: GTCTCCATCTTCATATGGTAA reverse: CCACCTTCTTGATGTCATCAT p63 α isoforms:
forward: GTCTCCATCTTCATATGGTAAC reverse: CACACTGACTGTAGAGGCA β isoforms:
forward: AAACGTACAGGCAGCAGCA reverse: CTTGCCAAATCCTGACAATGCTGC γ isoforms:
forward: GAGGATAGCATCAGAAAACAGCAAG reverse: CTCCACAAGCTCATTCCTGAAGC.
RESULTS
∆ Np63α interacts in vivo with three different regions of the p57 Kip2 gene. A prerequisite for activity of a transcription factor on a putative target gene is the finding that it is bound to relevant sequences in vivo. The chromatin immunoprecipitation technique (ChIP) is capable to determine whether this is the case for p63 in the p57 Kip2 gene locus. We used the human keratinocytes HaCaT cell line for chromatin preparation and three different anti-p63 antibodies. As controls, we used anti-YB and anti-p53 antibodies. Note that HaCat cells express almost exclusively the ∆Np63α isoform, as well as two p53 alleles mutated in the DNA-binding domain. 23 We scanned the p57 Kip2 locus with different primers. As shown in Figure 2A , of the six amplicons used, three are strongly positive for p63: -1600, the core promoter at -200 and +1000. The two latters are also positive for NF-Y, a result well expected given the presence of consensus CCAAT boxes in the area. None of the amplicons was positive for p53, confirming the specificity of our ChIP procedure. The -2500 and +5000 regions were negative for all antibodies. The -900 amplicon did show enrichment in both NF-Y and p63 IPs, probably because of the length of our chromatin (1 Kb) that allowed some lateral amplification. However, this was far less pronounced than for the -1600 and core promoter amplicons. In order to verify whether the association of ∆Np63α with the p57 Kip2 gene was functional in these cells, total RNA was extracted from HaCat cells and used in RT-PCR reactions with oligonucleotides specific for the p57 Kip2 transcript: as shown in Figure 2B the p57 Kip2 mRNA is indeed expressed in HaCat cells.
Therefore, in growing HaCat cells, p63 is functionally associated in vivo to the p57 Kip2 gene at three different positions.
A -2191 bp fragment of the p57 Kip2 promoter is regulated by p63 isoforms. The ChIP experiments prompted us to tackle a functional analysis of the p57 Kip2 promoter, taking into accounts two facts: (1) a fragment of 1 kb of the p57 kip2 promoter was shown to be not responsive to p73 and p53 cotransfection: 15 (2) p63 binds to -1.6 Kb from the start site. We therefore employed a larger fragment of the p57 Kip2 promoter, up to -2191 bp, in transient transfection experiment in the HaCat cell line where p57 Kip2 is expressed endogenously: as shown in Figure 2C , transfection of serial doses of the TAp63α and TAp73β marginally affected the expression of the p57 kip2 promoter fragment while transfection of TAp73α and to a greater extent ∆Np63α induced its expression. We next performed cotransfection experiments of the -2191 p57 Kip2 promoter with all p63 isoforms, p53, TAp73α and TAp73β in the U2OS human osteosarcoma cell line, expressing p53 but not p63, to verify whether members of the p53 family could regulate its expression. As shown in Figure 3A , in the U2OS cells the -2191 p57 Kip2 promoter activity was marginally affected by cotransfection of serial doses of TAp63α, TAp63β, TAp63γ, p53 and TAp73β expression plasmids; on the other hand, cotransfection of TAp73α led to an increase of the basal activity of the -2191 promoter construct and all ∆Np63 isoforms similarly transactivate this promoter, with the ∆Nα isoform being the strongest transactivator (10 fold). We repeated the same experiments in the Saos-2 cell line, that express no p53 and no p63, and very similar results were obtained (data not shown).
In the murine mesenchymal cell line C3H10T(1/2), in which p57 Kip2 expression has been studied, 24 a completely different scenario was obtained: cotransfection of the ∆Np63 isoforms and TAp73α did not have any effect on the -2191p57Kip2 promoter activity, while p53, TAp73β and all TAp63 isoforms had a strong repressive effect on this promoter fragment (Fig. 3B) .
These data indicate that the ∆Np63 isoforms and p73α activated the -2191 p57 Kip2 promoter in the U2OS cell line, while the TAp63 isoforms had a strong repressive effect on the -2191 promoter in the C3H10T(1/2) cells and this activity was shared by p53 and TAp73β.
The -1600 region of the p57 Kip2 promoter is necessary for p63 action. In order to identify the region of the p57 Kip2 promoter responsible for the A B C observed regulation by ∆Np63 and TAp63 isoforms, we employed deletion constructs of the p57 Kip2 promoter 15, 21 in cotransfection experiments with the ∆Np63α isoform in the U2OS cell line and with the TAp63α isoform in the C3H10T(1/2) cell line. The results clearly showed that deletion of a region encompassing -2191 and -1550 bp of the p57 kip2 promoter resulted in substantial loss of both activation and repression by the ∆Np63α and TAp63α isoforms respectively ( Fig. 4A and 4B , compare the -2191 and the -1550 constructs): the -1550 bp construct retained however a residual two fold activation and repression in response to ∆Np63α and TAp63α cotransfection, suggesting that two regions of the p57 Kip2 promoter are sensitive to p63 overexpression and this is well in line with the ChIP data that showed p63 binding to the -1600 region and to the proximal promoter region (Fig. 2A) .
To further narrow the p63 responsive region we generated nested deletion of the -2191/-1550 region by PCR, generating the -1880 (not shown), -1778 and -1664 constructs. Cotransfection of these constructs in the U2Os cell line with ∆Np63α showed that indeed deletion of the region around -1600 (compare the -1664 and -1500 constructs, (Fig. 4A ) resulted in a significant loss of activation by ∆Np63α cotransfection. This region was necessary also for repression by the TA isoforms in the the C3H10T(1/2) cell line (Fig. 4B) . These results indicate that the same region of the p57 Kip2 promoter around -1600 is responsible for the activation seen in the U2OS cell line by ∆Np63s and for the repression seen with TAp63s in the C3H/10T(1/2) cell line. Moreover, two regions of the p57 Kip2 promoter are responsive to p63: the -1600 region and the core promoter region.
The AEC natural p63 mutations subvert p57 Kip2 regulation. The initial observation of the partial overlap between the p57 Kip2 null mice, the p63 null mice phenotypes and the patients affected by syndromes associated to p63 mutations, prompted us to analyze the activities of natural p63 mutants associated with four different human syndromes on the -2191 p57 Kip2 promoter fragment. Cotransfections experiments of natural p63
Regulation of the Cyclin-Dependent Kinase Inhibitor p57 Kip2 Expression by p63 (Fig. 5A) . The TA mutant isoforms behaved as the wild type TA isoform, having no effect on the basal level of the p57 Kip2 promoter, with the exception of the TA-AEC518 that had a strong activation capacity. In the C3H10T(1/2) cotransfection of the ∆N mutant isoforms did not have effect on the activity of the -2191 promoter construct, behaving like wild type ∆Np63α. On the other hand, of the TA isoforms only the TA-AEC518 isoform was ineffective in repressing the basal activity of the -2191 construct while the other three mutants retained this ability. These data demonstrate that p57Kip2 regulation is profoundly altered in the AEC p63 mutant.
The endogenous p57 Kip2 gene is activated by ∆Np63 overexpression. Our data indicated that members of the p63 family regulate the expression of a p57 Kip2 promoter fragment when overexpressed and that some of the p63 mutants analysed were impaired in this activity. In order to verify whether the endogenous p57 Kip2 gene was subject to the same regulation as the promoter construct used, we transiently transfected the U2Os and Saos-2 cell lines with wild type and mutated ∆Np63 isoforms. The day after trasfection, total RNA was extracted and used in RT-PCR reactions with oligonucleotides specific for the p57 Kip2 transcript. As shown in Figure 6A and 6B, the p57Kip2 was activated in response to ∆Np63α, ∆Np63β and ∆Np63∆γ overexpression (lanes 2, 3 and 4) . The ∆N-EEC, ∆N-SHFM and ∆N-∆AAp63 mutants were still able to activate p57 Kip2 gene expression (lanes 6, 7 and 8) while the ∆N-AEC518 mutant completely failed to do so (lanes 5). In accordance with these data, the endogenous p57 Kip2 protein levels were increased upon ∆Np63α transfection (Fig. 6C) . These data indicate that the ∆Np63 isoforms transactivate endogenous p57 Kip2 gene expression and this activity is lost in the AEC natural p63 mutant.
DISCUSSION
Precise control of cell cycle progression is believed to be critical for normal development, while oncogenesis may be a direct result of its disturbance. Cell cycle progression is regulated predominantly by a series of serine/threonine kinases, the cyclin-dependent kinases (CDKs). The activities of the CDKs are controlled by a group of molecules that inhibit CDK activity, the CDK inhibitors (CKIs). It is widely believed that precise regulation of CKI expression is critical for appropriate development and that breakdown of this regulatory mechanism is deeply involved in oncogenesis and abnormal development. Evidence for this has been provided by the observation that some CKI knockout mice show developmental abnormalities and a predisposition to cancer development.
To date, seven CKIs have been identified in mammals and categorized into two families, the Cip/Kip and Ink4 families. The Cip/Kip family is composed of p21 Cip1 , p27 Kip1 and p57 Kip2 and is well conserved phylogenetically but, despite the structural and biochemical similarities among the Cip/Kip members, the phenotypes of knockout mice of each Cip/Kip member are surprisingly different and the p57 Kip2 is the only CDK inhibitor to be required for a correct embryogenesis. The p57 Kip2 protein ceases to be expressed in most organs as an embryo completes its development, in contrast to p27 Kip1 , the expression of which remains constant after birth, implying that p57 Kip2 plays an important role predominantly in early organogenesis. Most p57-deficient mice die immediately after birth due to dyspnea resulting from severe cleft palate, abdominal muscle defects and skeletal abnormalities due to bone ossification defects. 12, 14 About 10% of the p57-deficient mice survived beyond the weaning period without showing cancer predisposition.
Little is known about p57 Kip2 transcriptional regulation while that of p21 Cip1 has been investigated extensively 25, 26 and turned out to be quite complex; similarly, the regulation of p27 Kip1 seems equally articulated. 27 Here we report that the cyclin-dependent kinase inhibitor p57 Kip2 gene is a target for p63 mediated transcriptional activation and repression and that three regions of the p57 Kip2 gene are bound by p63 in vivo. The ChIP analysis performed with three anti-p63 antibodies determined that the p57 Kip2 gene is bound by the p63 protein in vivo. Interestingly, the scanning analysis suggests that there are three major areas of binding: an upstream region, which is the focus of the functional analysis perfomed, the core promoter and a downstream region, whose functional importance was not investigated in the present study. Neither the upstream, nor the core promoter contain bona fide p53 binding sites, suggesting that p63 recognizes DNA through different motifs, or that other DNA-binding factors mediate the association. 28 The upstream binding site has been funtionally dissected. Members of the p53 family, p53 and p73β, failed to induce the -2191 bp p57 kip2 promoter fragment, while p73α and all ∆Np63 isoforms induced its expression both in HaCat and U2Os cells; all TAp63 isoforms did not alter promoter activities in these cells. On the other hand, the TAp63 isoforms, p53 and p73β had a strong repressor activity in C3H10T(1/2) cells where all ∆Np63 and p73α were totally inert. The different behaviour of p63, p53 and p73 in Regulation of the Cyclin-Dependent Kinase Inhibitor p57 Kip2 Expression by p63 
A B
Regulation of the Cyclin-Dependent Kinase Inhibitor p57 Kip2 Expression by p63 the four cell lines used can be due to differential expression of still unknown cofactors that can stimulate/repress p53 family members activities. The differential ability of various p63 isoforms to induce target genes expression has been described in previous studies. 29, 30 Our attempts to delineate a p63-responsive element in the -2191 promoter region of p57 Kip2 have led to the identififcation of a 100 bp fragment that, when deleted, cause a drastic reduction of p63 activation in U2Os cells and a concomitant reduction of repression in C3H10T(1/2) cells, suggesting that both activation and repression are mediated by the same 100 bp region. We further dissected this fragment in EMSA experiments with nuclear extracts derived from cells expressing exogenous and endogenous p63 (not shown); all our attempts to evidenziate p63 binding to this region failed. It is well possibile that the conditions employed for binding are not optimal for p63 binding but we rather think that that other DNA-binding factors mediate the association. 28 A second p63 site was detected in the core promoter region. Here, again, no p53 element is found. We note that there are multiple CCAAT boxes in the promoter; CCAAT boxes are recognized and activated by the NF-Y trimer. NF-Y was recently shown to be required for the association of p53 to promoters of G 2 /M controlling genes in mouse NIH3T3, in the absence of p53-binding sites. 31 Indeed, p57 kip2 ChIPs positivity for NF-Y is limited to the core promoter and the +1000 region: the presence of multiple CCAAT in the core promoter suggests that indirect binding of p63 through CCAATbound NF-Ys is the likeliest possibility to explain p63 positivity in the core promoter. Association of ∆Np63α with multiple CCAAT promoters through direct protein-protein recruitment has been observed (Testoni B, Mantovani R, submitted).
The ∆Np63α is known to behave as a domint negative factor for p53 transcriptional activity. HaCat keratinocyets contain two mutant p53 alleles: 23 consistent with this, none of these binding sites are recognized by p53 in our study. We and others have shown that this isoform, which is devoid of the N-terminal activation domain, is nevertheless capable to activate p53 targets. 29, 32 One important finding from our study is that indeed ∆Np63α is the most potent of activators among the different isoforms on the p57 Kip2 promoter. Together with the ChIP data, this strongly suggests that p57 Kip2 is a physiological target in vivo of this isoform. The TA domain is evidently dispensable for this, and p53 is manifestly not involved. It was important to control this, since p53 mutated in the DNA-binding domain are known to possess a higher affinity for p63 and p73. HaCat keratinocyets contain two mutant p53 alleles: 23 consistent with this, none of these binding sites are recognized by p53 in our study. 33 Thus it is not through heterotetramerization that the p63 presumed tetramer works, equally indicating that activation is not brought by the p53 TA domain. Hence, the additional activation domain identified at the C-terminal of the ∆Np63α is manifestly providing the activation potential. 29 In general, these data strengthen the notion that bona fide targets of this isoform exist that are solely activated, and not repressed.
The AEC p63 mutation profoundly affected p63 trascriptional activity, turning the ∆N isoform in a weak activator of the p57 Kip2 promoter and the TA isoform in an activator instead of a repressor. This scenario suggests that during development the expression of the p57 kip2 gene would be differentially regulated by the same pattern of genes in different cell types. The observation of a clear alteration of p57 Kip2 expression by ∆Np63AEC mutants, together with the fact that p57 kip2 null mice mice share similar features with AEC patients (cleft lips and palates) suggests that p57 Kip2 may act in the developmental pathways altered in AEC ectodermal displasia. We have evidences that only the ∆Np63 isoforms are expressed during mouse development from E10 through E14 in the limb buds and in the branchial arches (manuscript in preparation) and mounting evidence suggests that the ∆Np63α isoform is predominant in stem cells of multilayered epithelia, in particular keratinocytes. 34, 35 Because AEC patients also have dermatological abnormalities, 36 abnormal regulation of p57 kip2 as suggested by our experiments might contribute to the emergence of the skin phenotype as well. 
